Current Month 2009
Article Features
  3-Week Course of Breast Radiation May Be as Effective as Conventional 5- to 7-Week Course for Early Breast Cancers
Additional, Specialized Radiation to Internal Mammary Chain Lymph Nodes May Not Be Necessary for Some Women after Mastectomy
Alternative to Invasive Biopsy of Palpable Breast Lesions with Benign Imaging Features
Breast Density Associated with Increased Risk of Cancer Recurrence
Breast Tenderness During Hormone Replacement Therapy Linked to Elevated Cancer Risk
Common Pain Relief Medication May Encourage Cancer Growth
Compound in Coffee Found to be Estrogenic
Drugs to Treat Anemia in Cancer Patients Linked to Thromboembolism
Experimental Agent Reduces Breast Cancer Metastasis to Bone
Fertility Procedures Need Not Delay Breast Cancer Treatment for Younger Women
Persistent Pain Common for Many Women 2 to 3 Years After Breast Cancer Treatment
Plastic Surgeons Offer Microsurgery Technique for Breast Reconstruction, Tummy Tuck After Mastectomy
Scientists Identify a Cellular Pathway by which Alcohol May Promote Cancer Progression
Simple Blood Test Could Reduce Repeat Breast MRI Scans in Premenopausal Women with Irregular Periods
Study Shows Family Caregivers, Simple Touch Techniques Reduce Symptoms in Cancer Patients
Using Adjuvant Radiotherapy to Control Borderline-Malignant and Malignant Phyllodes Tumors


CISNET Study Finds That Mammography Every Other Year May Be Sufficient for Women with Average Breast Cancer Risk

Please see Hopkins statement regarding these recommendations!

A comprehensive analysis of various mammography screening schedules suggests that biennial (every two years) screening of average risk women between the ages of 50 and 74 achieves most of the benefits of annual screening, but with less harm. The results represent a unanimous consensus of six independent research groups from various academic institutions. Their findings are published in the journal Annals of Internal Medicine.

Researchers from CISNET, the NCI-funded Cancer Intervention and Surveillance Modeling Network, used independent models to examine 20 screening strategies with different starting and stopping ages and intervals. Modeling estimates the lifetime impact (outcomes including benefits and harms) of breast cancer screening mammography. The CISNET models link known data across the course of life and include national data on age-specific breast cancer incidence, mortality, mammography characteristics and treatment effects.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon